TcrossGlobal

Efficacy of Evolocumab in End-Stage Renal Failure Patients with Polyvascular Disease Undergoing PCI

In hemodialysis patients with polyvascular disease undergoing PCI, treatment with evolocumab in addition to statin therapy significantly lowered LDL-C and significantly reduced the combined risk of major cardiovascular and lower major extremity events. Dr. Keiichi Hishikari of Yokosuka Kyosai Hospital presented at the Late Breaking Clinical Trials session of the 87th Annual Scientific Meeting of the Japanese Circulation Society.

In this study, 218 dialysis patients scheduled for PCI, receiving statin therapy, and with polyvascu...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.